98219801 - CELEST

Information

  • Trademark
  • 98219801
  • Serial Number
    98219801
  • Filing Date
    October 11, 2023
    a year ago
  • Transaction Date
    October 30, 2024
    6 months ago
  • Status Date
    October 30, 2024
    6 months ago
  • Location Date
    October 30, 2024
    6 months ago
  • Status Code
    661
  • Current Location
    TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    SEGAL, MOLLY
  • Attorney Docket Number
    39957/3542CE
    Attorney Name
    Jonathan M. Gelchinsky
    Law Office Assigned Location Code
    L50
  • Owners
Mark Drawing Code
4
Mark Identification
CELEST
Case File Statements
  • GS0051: Drug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds directed to lipid nanoparticles for the purpose of delivering pharmaceutical preparations to specific target tissue sites; drug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds and agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations; drug delivery agents consisting of pharmaceutical preparations and therapeutic agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations for RNA, gene therapy and mRNA regulation; drug delivery agents consisting of pharmaceutical and biological preparations for medical use that facilitate the release and delivery of a wide variety of pharmaceutical preparations for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; drug delivery agents consisting of pharmaceutical preparations that facilitate the release and delivery of a wide variety of pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation; pharmaceutical preparations, namely, vaccines
  • GS0011: Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acids and modified nucleic acids, namey, short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes
  • GS0421: Research and development in the field of technology and engineering, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, drug delivery agents and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, drug delivery agents and assays for use in pharmaceutical and biomedical industry
Case File Event Statements
  • 10/14/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/16/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/26/2024 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/17/2024 - 11 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/17/2024 - 11 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/15/2024 - 9 months ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 7/15/2024 - 9 months ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 10/4/2024 - 7 months ago
    10 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/4/2024 - 7 months ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/17/2024 - 11 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/4/2024 - 7 months ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/4/2024 - 7 months ago
    9 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/4/2024 - 7 months ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/30/2024 - 6 months ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/30/2024 - 6 months ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/30/2024 - 6 months ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA